NSE filing, NSE: VENUSREM. Summary written from the filing by ALFA Finder's alert engine.
Venus Remedies Ltd: key numbers
- Share price
- ₹1,303.60
- Market cap
- ₹1,743 Cr
- Revenue (annual)
- ₹769.6 Cr
- Net profit (annual)
- ₹102.8 Cr
- P/E (TTM)
- 14.3×Sector 46.1×
- Promoter holding
- 41.76%+0.00% QoQ
- FII holding
- 3.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venus Remedies Ltd
All →Venus Remedies Q2 FY27 Results: Net Profit ₹25.6 Cr, Up 27.4% YoY
Venus Remedies Ltd reported revenue from operations of ₹218.8 Cr (+13.5% YoY) and net profit of ₹25.6 Cr (+27.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹25.6 Cr · +27.4% YoY
Venus Remedies Regulatory Approval
Venus Remedies Limited secured five marketing authorizations for drugs including Vancomycin and Meropenem across Kazakhstan, Peru, Kuwait, and Argentina. These regulatory approvals expand its global pharmaceutical portfolio.
Venus Remedies Board Meeting Date
Venus Remedies will hold a board meeting on 26th October 2026 to consider and approve its unaudited standalone and consolidated financial results for the September quarter.
Venus Remedies Other Announcement
Venus Remedies Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Venus Remedies Other Announcement
Venus Remedies Limited has announced a change in its Corporate Identification Number (CIN) following the alteration of its Memorandum of Association.
Venus Remedies Management Change
Venus Remedies Ltd announced the appointment and re-appointment of several Directors, including Executive and Independent Directors, following approval at its 37th Annual General Meeting.
Other other announcement announcements
All →Parth Electricals & Engineering Other Announcement
Parth Electricals filed its fifth Monitoring Agency Report for the quarter ended September 30, 2026. It confirms no deviation from the issue objects.
KHFM Hospitality & Facility Management Services Other Announcement
KHFM filed a non-applicability notice for the Corporate Governance Report for the quarter ended 30 September 2026, with a practising CS certificate. This is routine compliance paperwork with no business or financial event.
Motilal Oswal Financial Services Other Announcement
Motilal Oswal Financial Services certifies utilisation of proceeds from listed Commercial Papers issued in the quarter ended September 30, 2026, and adherence to listing conditions. This is a periodic regulatory compliance certificate.
Invigorated Business Consulting Other Announcement
Invigorated Business Consulting appointed GAV & Associates as statutory auditor from 1 April 2027 for 60 months. The routine appointment carries no financial impact.
- Execution
- 60 months from 1 April 2027
Boss Packaging Solutions Other Announcement
Boss Packaging Solutions Limited states that Regulation 27 corporate governance provisions do not apply to it for the quarter ended 30 September 2026, as an SME-listed company. This is a compliance non-applicability intimation with no business event.
Apar Industries Other Announcement
APAR Industries' QIP monitoring agency reported no fund deviation for the quarter ended September 30, 2026. Utilisation matches the offer document, with ₹560.14 crore unutilised.